However, TET2 was reported to play a regulatory role in myeloproliferative neoplasms and myelodysplastic syndromes in the form of functional deletion mutations [36], whereas TET1 and TET3 were rarely characterized of functional deletion mutations to function in hematological tumors [37]. The gene discussed is TET3; the disease is myeloproliferative neoplasm.